| UniProt ID | AL7A1_HUMAN | |
|---|---|---|
| UniProt AC | P49419 | |
| Protein Name | Alpha-aminoadipic semialdehyde dehydrogenase | |
| Gene Name | ALDH7A1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 539 | |
| Subcellular Localization |
Cytoplasm, cytosol . Nucleus . Isoform 1: Mitochondrion . |
|
| Protein Description | Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism.. | |
| Protein Sequence | MWRLPRALCVHAAKTSKLSGPWSRPAAFMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 (in isoform 2) | Acetylation | - | 15.54 | 19413330 | |
| 23 (in isoform 4) | Phosphorylation | - | 31.36 | - | |
| 30 | Phosphorylation | SRPAAFMSTLLINQP CCCHHHHHHHHHCCH | 14.95 | 25599653 | |
| 30 | Acetylation | SRPAAFMSTLLINQP CCCHHHHHHHHHCCH | 14.95 | 19413330 | |
| 39 | Phosphorylation | LLINQPQYAWLKELG HHHCCHHHHHHHHHC | 13.36 | 110745675 | |
| 57 | Acetylation | ENEGVYNGSWGGRGE CCCCCCCCCCCCCCE | 13.69 | 19413330 | |
| 67 | Phosphorylation | GGRGEVITTYCPANN CCCCEEEEEEECCCC | 19.52 | 28152594 | |
| 68 | Phosphorylation | GRGEVITTYCPANNE CCCEEEEEEECCCCC | 16.41 | 28152594 | |
| 69 | Phosphorylation | RGEVITTYCPANNEP CCEEEEEEECCCCCC | 6.44 | 24927040 | |
| 81 | Ubiquitination | NEPIARVRQASVADY CCCCHHHHHHHHHCH | 22.31 | 21890473 | |
| 84 | Phosphorylation | IARVRQASVADYEET CHHHHHHHHHCHHHH | 14.97 | 25159151 | |
| 88 | Phosphorylation | RQASVADYEETVKKA HHHHHHCHHHHHHHH | 13.11 | 110745683 | |
| 93 | 2-Hydroxyisobutyrylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | - | |
| 93 | Acetylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | 23236377 | |
| 93 | Succinylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | 27452117 | |
| 94 | Acetylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | 30585379 | |
| 94 | Succinylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | - | |
| 94 | Succinylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | - | |
| 100 | Acetylation | KKAREAWKIWADIPA HHHHHHHHHHCCCCC | 35.10 | 26051181 | |
| 109 | Ubiquitination | WADIPAPKRGEIVRQ HCCCCCCCCCHHHHH | 75.13 | 21890473 | |
| 124 | 2-Hydroxyisobutyrylation | IGDALREKIQVLGSL HHHHHHHHHHHHHHH | 31.82 | - | |
| 130 | Phosphorylation | EKIQVLGSLVSLEMG HHHHHHHHHHHHHHC | 22.80 | 20068231 | |
| 133 | Phosphorylation | QVLGSLVSLEMGKIL HHHHHHHHHHHCCEE | 24.73 | 20068231 | |
| 136 | Ubiquitination | GSLVSLEMGKILVEG HHHHHHHHCCEEEEC | 8.87 | 21890473 | |
| 136 | Sulfoxidation | GSLVSLEMGKILVEG HHHHHHHHCCEEEEC | 8.87 | 30846556 | |
| 163 | Sulfoxidation | YAVGLSRMIGGPILP HHHHHHHHHCCCCCC | 2.76 | 30846556 | |
| 171 | Phosphorylation | IGGPILPSERSGHAL HCCCCCCCCCCCCHH | 42.04 | 21406692 | |
| 222 | Phosphorylation | CLWKGAPTTSLISVA EECCCCCCHHHHHHH | 28.60 | 21406692 | |
| 223 | Phosphorylation | LWKGAPTTSLISVAV ECCCCCCHHHHHHHH | 22.07 | 21406692 | |
| 224 | Phosphorylation | WKGAPTTSLISVAVT CCCCCCHHHHHHHHH | 26.61 | 21406692 | |
| 227 | Phosphorylation | APTTSLISVAVTKII CCCHHHHHHHHHHHH | 14.87 | 21406692 | |
| 231 | Phosphorylation | SLISVAVTKIIAKVL HHHHHHHHHHHHHHH | 13.54 | 21406692 | |
| 249 | Phosphorylation | KLPGAICSLTCGGAD CCCCCEEECEECCCC | 22.17 | 21406692 | |
| 251 | Phosphorylation | PGAICSLTCGGADIG CCCEEECEECCCCHH | 7.88 | 21406692 | |
| 259 | Phosphorylation | CGGADIGTAMAKDER ECCCCHHHHHHCCCC | 17.37 | 21406692 | |
| 260 | Ubiquitination | GGADIGTAMAKDERV CCCCHHHHHHCCCCE | 7.24 | 21890473 | |
| 271 | Phosphorylation | DERVNLLSFTGSTQV CCCEEEEEEECCCHH | 24.75 | 21712546 | |
| 273 | Phosphorylation | RVNLLSFTGSTQVGK CEEEEEEECCCHHHH | 27.18 | 21712546 | |
| 275 | Phosphorylation | NLLSFTGSTQVGKQV EEEEEECCCHHHHHH | 16.77 | 21712546 | |
| 285 | Sulfoxidation | VGKQVGLMVQERFGR HHHHHHHHHHHHHHC | 2.11 | 30846556 | |
| 317 | Ubiquitination | DLSLVVPSALFAAVG CHHHHCHHHHHHHHC | 26.45 | 21890473 | |
| 324 | Ubiquitination | SALFAAVGTAGQRCT HHHHHHHCCCHHHCH | 12.72 | 29967540 | |
| 336 | Ubiquitination | RCTTARRLFIHESIH HCHHHHHHHHCHHHH | 3.84 | 21890473 | |
| 345 | Ubiquitination | IHESIHDEVVNRLKK HCHHHHHHHHHHHHH | 33.91 | 21890473 | |
| 352 | Malonylation | EVVNRLKKAYAQIRV HHHHHHHHHHHCCCC | 51.74 | 26320211 | |
| 352 | Ubiquitination | EVVNRLKKAYAQIRV HHHHHHHHHHHCCCC | 51.74 | 29967540 | |
| 354 | Phosphorylation | VNRLKKAYAQIRVGN HHHHHHHHHCCCCCC | 14.12 | 29496907 | |
| 361 | Ubiquitination | YAQIRVGNPWDPNVL HHCCCCCCCCCCCCC | 31.47 | 32015554 | |
| 362 | Ubiquitination | AQIRVGNPWDPNVLY HCCCCCCCCCCCCCC | 30.80 | 29967540 | |
| 375 | Ubiquitination | LYGPLHTKQAVSMFL CCCCCCHHHHHHHHH | 26.05 | 29967540 | |
| 379 | Phosphorylation | LHTKQAVSMFLGAVE CCHHHHHHHHHHHHH | 13.56 | 21406692 | |
| 388 | Ubiquitination | FLGAVEEAKKEGGTV HHHHHHHHHHCCCEE | 18.08 | 21890473 | |
| 389 | Ubiquitination | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 32015554 | |
| 389 | 2-Hydroxyisobutyrylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | - | |
| 389 | Acetylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 6570007 | |
| 389 | Succinylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 23954790 | |
| 390 | Ubiquitination | GAVEEAKKEGGTVVY HHHHHHHHCCCEEEE | 69.51 | 29967540 | |
| 390 | 2-Hydroxyisobutyrylation | GAVEEAKKEGGTVVY HHHHHHHHCCCEEEE | 69.51 | - | |
| 393 | Ubiquitination | EEAKKEGGTVVYGGK HHHHHCCCEEEECCE | 19.21 | 21890473 | |
| 402 | Ubiquitination | VVYGGKVMDRPGNYV EEECCEECCCCCCCC | 4.05 | 21890473 | |
| 411 | Ubiquitination | RPGNYVEPTIVTGLG CCCCCCCCEEEECCC | 19.85 | 29967540 | |
| 415 | Ubiquitination | YVEPTIVTGLGHDAS CCCCEEEECCCCCCH | 23.88 | 21890473 | |
| 424 | Ubiquitination | LGHDASIAHTETFAP CCCCCHHHCCCCCCC | 10.89 | 21890473 | |
| 436 | Ubiquitination | FAPILYVFKFKNEEE CCCEEEEEEECCHHH | 4.93 | 29967540 | |
| 439 | Acetylation | ILYVFKFKNEEEVFA EEEEEEECCHHHEEE | 65.13 | 20167786 | |
| 439 | Ubiquitination | ILYVFKFKNEEEVFA EEEEEEECCHHHEEE | 65.13 | 29967540 | |
| 452 | Ubiquitination | FAWNNEVKQGLSSSI EEEEHHHHHCCCCCC | 32.25 | 22817900 | |
| 457 | Phosphorylation | EVKQGLSSSIFTKDL HHHHCCCCCCCHHHH | 32.28 | 23403867 | |
| 458 | Phosphorylation | VKQGLSSSIFTKDLG HHHCCCCCCCHHHHH | 20.53 | 23403867 | |
| 462 | Acetylation | LSSSIFTKDLGRIFR CCCCCCHHHHHHHHH | 39.96 | - | |
| 464 | Ubiquitination | SSIFTKDLGRIFRWL CCCCHHHHHHHHHHH | 5.46 | 21890473 | |
| 472 | Ubiquitination | GRIFRWLGPKGSDCG HHHHHHHCCCCCCCE | 18.21 | 29967540 | |
| 473 | Ubiquitination | RIFRWLGPKGSDCGI HHHHHHCCCCCCCEE | 35.35 | 21890473 | |
| 478 | Glutathionylation | LGPKGSDCGIVNVNI HCCCCCCCEEEEEEC | 4.25 | 22555962 | |
| 491 | Ubiquitination | NIPTSGAEIGGAFGG ECCCCCCCCCCCCCC | 45.77 | 21890473 | |
| 500 | Acetylation | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 26051181 | |
| 500 | Ubiquitination | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 21890473 | |
| 500 | Ubiquitination | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 21890473 | |
| 509 | Ubiquitination | TGGGRESGSDAWKQY CCCCCCCCHHHHHHH | 25.45 | 21890473 | |
| 516 | Phosphorylation | GSDAWKQYMRRSTCT CHHHHHHHHHHCCCE | 6.72 | 28634298 | |
| 520 | Phosphorylation | WKQYMRRSTCTINYS HHHHHHHCCCEEEEC | 19.92 | 28634298 | |
| 521 | Phosphorylation | KQYMRRSTCTINYSK HHHHHHCCCEEEECC | 16.32 | 28634298 | |
| 523 | Phosphorylation | YMRRSTCTINYSKDL HHHHCCCEEEECCCC | 16.61 | 25944883 | |
| 526 | Phosphorylation | RSTCTINYSKDLPLA HCCCEEEECCCCCCC | 17.16 | 28152594 | |
| 527 | Phosphorylation | STCTINYSKDLPLAQ CCCEEEECCCCCCCC | 18.40 | 28152594 | |
| 528 | Ubiquitination | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 21890473 | |
| 528 | Acetylation | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 23954790 | |
| 528 | Malonylation | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 26320211 | |
| 537 | Ubiquitination | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | 21890473 | |
| 537 | Succinylation | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | - | |
| 537 | Succinylation | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AL7A1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL7A1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL7A1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| EPS8_HUMAN | EPS8 | physical | 21988832 | |
| ASNS_HUMAN | ASNS | physical | 22863883 | |
| CAN2_HUMAN | CAPN2 | physical | 22863883 | |
| IF5_HUMAN | EIF5 | physical | 22863883 | |
| AGAL_HUMAN | GLA | physical | 22863883 | |
| PDIA4_HUMAN | PDIA4 | physical | 22863883 | |
| PP1A_HUMAN | PPP1CA | physical | 22863883 | |
| RISC_HUMAN | SCPEP1 | physical | 22863883 | |
| 1433E_HUMAN | YWHAE | physical | 22863883 | |
| 1433G_HUMAN | YWHAG | physical | 22863883 | |
| 1433F_HUMAN | YWHAH | physical | 22863883 | |
| GABT_HUMAN | ABAT | physical | 26344197 | |
| CATA_HUMAN | CAT | physical | 26344197 | |
| CPT2_HUMAN | CPT2 | physical | 26344197 | |
| FAH2A_HUMAN | FAHD2A | physical | 26344197 | |
| AATC_HUMAN | GOT1 | physical | 26344197 | |
| HIBCH_HUMAN | HIBCH | physical | 26344197 | |
| PRDX5_HUMAN | PRDX5 | physical | 26344197 | |
| DHSO_HUMAN | SORD | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 266100 | Pyridoxine-dependent epilepsy (PDE) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...